Posts by Hannah Cifaldi
Hygieia Expands to Arizona, as Endocrinology Associates, PA, Joins d-Nav® Insulin Management Clinical Partnership Program
Partnership model gives physicians better tools for insulin therapy and offers new reimbursement opportunities Livonia, Michigan, Jan. 10, 2023 — Hygieia, a provider of digital therapeutics for insulin management, has added Endocrinology Associates, PA, in Scottsdale and Chandler, AZ, as a clinical partner. This makes Hygieia’s d-Nav® autonomous insulin therapy service available to patients with type…
Read MoreHygieia announces new CPT codes for autonomous insulin dose titration
Livonia, Mich., July 26, 2022 – Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology. d-Nav is the first FDA-cleared technology to autonomously adjust insulin dose recommendations…
Read MoreAutonomous Insulin Dose Adjustments: A Game-Changer in Type 2 Diabetes Care
Diabetes affects more than 37 million people in the U.S. and increases their risk of early death by 60%.1 Numerous clinical studies show that the maintenance of glycated hemoglobin (HbA1c) at about 7% prevents complications, slows the disease progression, and prevents premature death. Despite advances in pharmacotherapy, most patients with long-standing type 2 diabetes progress…
Read MoreHygieia Advances its Global Business Development Activities with d-Nav® Program in Israel
Livonia, Michigan, June 23, 2022 – Hygieia, a digital therapeutics company for insulin therapy, has successfully licensed its d-Nav insulin management technology to Movement Group, a provider of health and wellness programs to integrated health delivery networks in Israel. The agreement is part of an accelerated strategy to expand its d-Nav insulin titration technology globally. d-Nav…
Read MoreWhat HbA1c level do I need to aim for?
If you have diabetes, you have most likely heard that you should aim for an HbA1c measure of 7 percent or lower. But what does this really mean? HbA1c is a measure of average glucose over a period of about 2-3 months. It essentially evaluates how much glucose binds to your hemoglobin. Since red blood…
Read MoreHygieia Launches d-Nav® Clinical Partnership Program at AACE Annual Meeting
SAN DIEGO, Calif.–(BUSINESS WIRE)–Hygieia, a digital therapeutics company, today announced the official launch of its d-Nav Clinical Partnership Program for endocrinology practices treating patients with type 2 diabetes. The d-Nav Clinical Partnership Program is turnkey. It provides patients with access to d-Nav autonomous insulin dose technology and a clinical support team. For clinical partners, the d-Nav…
Read More